Skip to main navigation Skip to search Skip to main content

A Study to Evaluate the Natural History of Secondary Progressive Multiple Sclerosis in Never-Treated or Late Starters Compared to Early Treated Patients

Project: Research

Project Details

StatusFinished
Effective start/end date12/18/21 → 06/30/25

Funding

  • Novartis Pharmaceuticals Corporation: $124,505.00